Opioids

Only 16% of discharge doses were within 5 MME of inpatient daily consumption, study showed

Australian trial finds no difference in pain scores over 6 weeks

Almost all procedures had an increase in both types of prescribing, Medicare data showed

A Narcan kind of weekend

OTC agents are not safe alternatives to prescription opioids, study suggests

In non-responsive patients, think polysubstance use, says addiction treatment expert Kelly Ramsey

Black women less likely to start buprenorphine

Longer-acting nasal spray to be available by end of the year

It comes down to funding -- but it's time for that to change

Suicide prevention in traumatic brain injury survivors also on the docket during hearing

"A great need to reduce medication treatment in this vulnerable population," says researcher

Legal ambiguity is preventing doctors from best serving patients

Differences emerged despite similar numbers of healthcare visits

There is no justification to oppose increased access to naloxone